Zymeworks (ZYME) Short-term Investments (2021 - 2026)

Zymeworks has reported Short-term Investments for 6 years, with the latest figure at $120.4 million in Q1 2026.

• Quarterly Short-term Investments fell 36.3% year-over-year to $120.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $120.4 million (down 36.3% YoY) and the FY2025 annual result came in at $187.6 million, up 17.52% from the prior year.
• Short-term Investments eased to $120.4 million in Q1 2026 per ZYME's latest filing, from $187.6 million in the prior quarter.
• Over five years, Short-term Investments peaked at $259.2 million in Q2 2024 and troughed at $70.2 million in Q3 2022.
• A 5-year average of $175.2 million and a median of $187.1 million in 2025 frame the typical range for Short-term Investments.
• The sharpest annual moves came in 2023 and 2026: Short-term Investments soared 186.59% in 2023, then slumped 36.3% in 2026.
• Over 5 years, Short-term Investments stood at $91.3 million in 2022, then surged by 137.37% to $216.8 million in 2023, then dropped by 26.34% to $159.7 million in 2024, then increased by 17.52% to $187.6 million in 2025, then plunged by 35.81% to $120.4 million in 2026.
• According to Business Quant data, Short-term Investments over the past three periods registered $120.4 million, $187.6 million, and $187.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.